Cannabigerol (CBG)
What it is
A non-intoxicating phytocannabinoid known as the 'mother cannabinoid' because CBGA is the biosynthetic precursor from which THCA, CBDA, and CBCA are derived. CBG acts at CB1/CB2 receptors weakly but more strongly at alpha-2 adrenergic, 5-HT1A, and TRPA1/TRPV1 channels. Preclinical evidence is strong for anti-inflammatory, antibacterial (including MRSA), and appetite-stimulating effects. Human trials are early but emerging data suggest focus, mood, and IBD symptom benefits. Legal status varies by jurisdiction — check local laws.
Dose
10–50 mg per dose; product strength varies widely — start low
Time of day & tips
Verify product is legal in your jurisdiction; choose broad-spectrum from reputable labs with COAs; less sedating than CBD; may interact with CYP3A4 and CYP2D6 substrates
Compare or learn more
Compare with another supplement →
Browse by symptom →
Open the full interactive view →